Shingles Prevention in Older Adults

Shingles is a common condition, affecting about 1 in 3 U.S. adults. It typically presents as a painful, itchy, and tingling rash and can lead to serious complications, including vision loss and long-term nerve pain in the area where the rash occurs. The good news is that an effective vaccine is available. Shingrix is over 90% effective at preventing shingles and its complications. It is recommended as a two-dose series, 2–6 months apart, for adults aged 50 and older. Patients can still receive the vaccine even if they’ve had shingles before, as it can help prevent future episodes. However, vaccination should be delayed until the rash has completely resolved.

Most side effects are mild and short-lived, including redness, muscle pain, headache, and fever. These typically resolve within 3 days. More serious events like Guillain-Barré syndrome have rarely been reported.

The vaccine is available at no cost to patients with Medicare Part D. Pharmacists can create awareness about this vaccine, make strong recommendations, and address patient concerns.

For more information, visit the Centers for Disease Control and Prevention website for up-to-date guidance on shingles and vaccine safety and effectiveness.